These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8847548)

  • 1. Inhibition of lipid peroxidation in central nervous system trauma and ischemia.
    Hall ED
    J Neurol Sci; 1995 Dec; 134 Suppl():79-83. PubMed ID: 8847548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
    Hall ED
    Eur J Anaesthesiol; 1996 May; 13(3):279-89. PubMed ID: 8737119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).
    Althaus JS; Andrus PK; Williams CM; VonVoigtlander PF; Cazers AR; Hall ED
    Mol Chem Neuropathol; 1993 Oct; 20(2):147-62. PubMed ID: 8297419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
    Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL
    Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
    Smith SL; Scherch HM; Hall ED
    J Neurosurg; 1996 Feb; 84(2):229-33. PubMed ID: 8592225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.
    Hall ED; McCall JM; Means ED
    Adv Pharmacol; 1994; 28():221-68. PubMed ID: 8080818
    [No Abstract]   [Full Text] [Related]  

  • 8. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
    Kim H; Koehler RC; Hurn PD; Hall ED; Traystman RJ
    Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tirilazad mesylate (Freedox)--an effective inhibitor of lipid membrane peroxidation].
    Sániová B
    Bratisl Lek Listy; 1997 Jun; 98(6):339-42. PubMed ID: 9333426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxygen radicals in traumatic injury: clinical implications.
    Hall ED
    J Emerg Med; 1993; 11 Suppl 1():31-6. PubMed ID: 8445200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders.
    Hall ED
    Ann Neurol; 1992; 32 Suppl():S137-42. PubMed ID: 1510373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection.
    Kavanagh RJ; Kam PC
    Br J Anaesth; 2001 Jan; 86(1):110-9. PubMed ID: 11575384
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid antioxidants in acute central nervous system injury.
    Hall ED
    Ann Emerg Med; 1993 Jun; 22(6):1022-7. PubMed ID: 8503522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic potential of lazaroids (21-aminosteroids). A recent survey].
    Buttgereit F; Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1997 Oct; 122(44):1363-7. PubMed ID: 9410710
    [No Abstract]   [Full Text] [Related]  

  • 17. Possibilities of brain protection with tirilazad after cardiac arrest.
    Sterz F; Janata K; Kürkciyan I; Müllner M; Malzer R; Schreiber W
    Semin Thromb Hemost; 1996; 22(1):105-12. PubMed ID: 8711485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radicals in CNS injury.
    Hall ED; Braughler JM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.
    Hall ED; Braughler JM; Yonkers PA; Smith SL; Linseman KL; Means ED; Scherch HM; Von Voigtlander PF; Lahti RA; Jacobsen EJ
    J Pharmacol Exp Ther; 1991 Aug; 258(2):688-94. PubMed ID: 1865365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation.
    Wang Y; Mathews WR; Guido DM; Jaeschke H
    J Pharmacol Exp Ther; 1996 May; 277(2):714-20. PubMed ID: 8627550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.